Cargando…
A Breathe in Cystic Fibrosis Therapy: A New Therapeutic Endeavor for Cysteamine
Autores principales: | De Stefano, Daniela, Maiuri, Maria Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634771/ https://www.ncbi.nlm.nih.gov/pubmed/26629521 http://dx.doi.org/10.1016/j.ebiom.2015.09.038 |
Ejemplares similares
-
Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation
por: Ferrari, Eleonora, et al.
Publicado: (2017) -
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
por: Tosco, A, et al.
Publicado: (2016) -
Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex
por: Fraser-Pitt, Douglas, et al.
Publicado: (2016) -
An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis
por: Devereux, Graham, et al.
Publicado: (2016) -
Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages
por: Shrestha, Chandra L., et al.
Publicado: (2017)